• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.29%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    107.11 Up 1.57(1.49%) Jan 26, 4:00PM EST
    |After Hours : 107.20 Up 0.09 (0.08%) Jan 26, 7:57PM EST
    Add to Portfolio
    Prev Close:105.54
    Open:105.07
    Bid:106.22 x 100
    Ask:N/A
    1y Target Est:122.58
    Beta:1.18
    Earnings Date:Feb 3 - Feb 4 (Est.)
    Day's Range:104.87 - 107.77
    52wk Range:63.50 - 116.83
    Volume:10,307,537
    Avg Vol (3m):17,505,400
    Market Cap:161.59B
    P/E (ttm):19.08
    EPS (ttm):5.61
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):10.87
    P/S (ttm):7.69
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :7.89
    Quarterly EPS Est (Dec-14) :2.19
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):0.40

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback